News

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...
Highlights Walking pneumonia is a milder form of regular pneumonia. It can be contagious when caused by specific bacteria or ...
Vermont has the second lowest state fatality rate in the US (147.3 per 100K; Hawaii 112.9/100K). Mississippi (464.7/100K) and ...
The nation’s infant mortality rate dropped last year after two years of hovering at a late-pandemic plateau. Some ...
Africa CDC Director General Dr. Jean Kaseya has called for the review, which will be led by the institution’s Emergency Consultative Group (ECG) under the chairmanship of renowned epidemiologist ...
A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.
Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.
Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.
Babies treated with nirsevimab had an 83% reduced risk of hospitalization due to RSV infection ... Centers for Disease Control and Prevention (CDC) recommends that all babies be protected ...
There was a significant drop in the number of babies hospitalized with RSV this year; a positive news story that can be ...
The Centers for Disease Control and Prevention May 8 released an analysis that found declines in hospitalizations for infants infected with respiratory syncytial virus during the 2024-2025 RSV season.